The extravascular penetration of tirapazamine into tumours: a predictive model of the transport and efficacy of hypoxia specific cytotoxic analogues and the potential use of cucurbiturils to facilitate delivery Online publication date: Fri, 24-Nov-2017
by Clifford W. Fong
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 10, No. 4, 2017
Abstract: A multiparameter model of the diffusion, antiproliferative assays IC50 and aerobic and hypoxic clonogenic assays for a wide range of neutral and radical anion forms of tirapazamine (TPZ) analogues has found: a) extravascular diffusion is governed by the desolvation, lipophilicity, dipole moment and molecular volume; b) hypoxic assay properties of the TPZ analogues show dependencies on the electron affinity, lipophilicity and dipole moment and desolvation; c) aerobic properties are mainly dependent on the electron affinity, involving free radicals in the extracellular matrix. The model shows that ligand water desolvation and lipophilicity are the dominant processes governing the DNA intercalation of TPZ analogues, consistent with DFT modelling of the complexes formed by TPZ analogues with neutral and N-protonated acridine moieties which intercalate with the guanine DNA nucleobases. It is shown that TPZ can form stable complexes with cucurbit[7]uril as a precursor to proof of principle of improved TPZ delivery to tumours.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com